Today: 20 May 2026
NatWest share price rises in early London trade after fresh buyback filing — what to watch next
15 January 2026
1 min read

NatWest share price rises in early London trade after fresh buyback filing — what to watch next

London, Jan 15, 2026, 08:50 GMT — Regular session.

  • NatWest shares climbed roughly 1.2% in early London trading.
  • The bank revealed additional share buybacks as part of its ongoing repurchase programme.
  • Investors are eyeing the Feb. 13 annual results for fresh guidance on targets and plans for capital returns.

NatWest Group (NWG.L) shares climbed 1.2% to 637.8 pence by 0850 GMT on Thursday, pushing ahead of the broader FTSE as the bank announced additional buybacks in routine filings.

A steady stream of repurchase notices has kept the spotlight on shareholder returns, even as UK bank stocks fluctuate with shifts in interest-rate expectations and global risk appetite.

This matters now because NatWest’s next major event is near enough for investors to begin adjusting their positions. Medium-term targets and the pace of buybacks usually get revisited when full-year results drop, and faster-than-expected UK rate cuts could shift the calculations for bank profits.

NatWest announced it purchased 842,406 shares on Jan. 14 at a volume-weighted average price of 630.97 pence, under its ongoing buyback programme. The bank confirmed these shares are set for cancellation.

According to a filing, the bank snapped up 845,398 shares on Jan. 13 at a volume-weighted average price of 630.81 pence, also via Merrill Lynch International.

It’s been a volatile scene. On Wednesday, London’s FTSE 100 hit a new high, lifted by gains in miners and healthcare shares. Investors weighed clues on the future of interest rates, while XTB’s Kathleen Brooks pointed to geopolitical risks funneling money into gold’s relative safety.

On the banking front, Morgan Stanley noted Wednesday that NatWest’s upcoming full-year results might include revised medium-term goals. The firm expects NatWest to set an 18% return-on-tangible-equity target for 2028. It also highlighted a potential cut in NatWest’s “go-to” common equity tier 1 ratio from the current 13%-14% range down to 13%. That shift could unlock more capacity for distributions. Meanwhile, Morgan Stanley trimmed its NatWest buyback forecast to £1 billion, down from £1.25 billion, citing higher anticipated Basel-related risk-weight inflation. Investing.com Australia

The upside scenario still hinges on two risks that could flip the script: the speed of rate cuts and the capital requirements tied to fresh regulations. Should margins shrink quicker than anticipated, or if regulators raise capital demands, buybacks could stall and the stock might lose momentum.

NatWest will release its annual results on Friday, Feb. 13, followed by a management presentation that same morning, the bank’s investor information shows.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
BP stock slides in London as $5 billion write-down warning puts buyback in focus
Previous Story

BP stock slides in London as $5 billion write-down warning puts buyback in focus

Broadcom stock falls again as China targets VMware; RBC says OpenAI upside ‘less clear’
Next Story

Broadcom stock falls again as China targets VMware; RBC says OpenAI upside ‘less clear’

Go toTop